NDC codes

FDA NDC Directory
Product NDC (as listed)24658-802Labeler and product segments. Claims need a package NDC.
Product NDC at billing width24658-0802Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
24658-802-60246580802602465808026060 CAPSULE in 1 BOTTLE (24658-802-60)Marketed from Mar 14, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Rifampin
Generic name (nonproprietary)
rifampin
Active ingredients
Rifampin — 300 mg/1
Dosage form
Capsule
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 064150
Marketing start
Listing expires
Other FDA classes
Rifamycins (Chemical structure)
Identifiers
Product ID 24658-802_1e50fbd4-91eb-4d25-a90d-1907c3a0ec02SPL ID 1e50fbd4-91eb-4d25-a90d-1907c3a0ec02SPL set ID 28109dee-3e5e-492b-b7d9-9ba46c0b5324RxCUI 198201, 198202UNII VJT6J7R4TRUPC 0324658801308, 0324658802602
Pharmacologic class
Rifamycin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424658080260 followed by a unit qualifier and the quantity

Package 24658-0802-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampin and they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to rifampin and the patient is not responding to therapy, the drug regim…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 24658-802

What is NDC 24658-802?
24658-802 is the product NDC for Rifampin, Rifampin 300 mg/1 capsule, listed with the FDA by PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Rifampin.
What is the active ingredient?
Rifampin.
Who is the labeler?
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS, NDC labeler code 24658. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rifampin?
18 other product NDCs are listed under this name. See all Rifampin NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rifampin NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
RifampinRifampin 150 mg/1CapsuleOralANI Pharmaceuticals, Inc.70954-89270954-0892-1070954-0892-20
RifampinRifampin 300 mg/1CapsuleOralANI Pharmaceuticals, Inc.70954-89370954-0893-1070954-0893-2070954-0893-30
RifampinRifampin 150 mg/1CapsuleOralCoupler LLC67046-160567046-1605-03
rifampinRifampin 300 mg/1CapsuleOralMajor Pharmaceuticals0904-731500904-7315-61
RifampinRifampin 150 mg/1CapsuleOralPURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS24658-80124658-0801-30
RifampinRifampin 300 mg/1CapsuleOralEPIC PHARMA, LLC42806-79942806-0799-0142806-0799-0542806-0799-30+1 more
RifampinRifampin 150 mg/1CapsuleOralEPIC PHARMA, LLC42806-80142806-0801-0142806-0801-30
RifampinRifampin 300 mg/1CapsuleOralAmerican Health Packaging60687-58660687-0586-01
RifampinRifampin 150 mg/1CapsuleOralAmerican Health Packaging60687-57560687-0575-21
RifampinRifampin 600 mg/1Injection, Powder, Lyophilized, For solutionIntravenousHikma Pharmaceuticals USA Inc.0143-923000143-9230-01

All 19 Rifampin NDCs

Other NDCs under ANDA 064150

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 064150
ProductStrengthForm · routeLabelerProduct NDC
RifampinRifampin 150 mg/1CapsuleOralEPIC PHARMA, LLC42806-801
RifampinRifampin 300 mg/1CapsuleOralEPIC PHARMA, LLC42806-799
RifampinRifampin 150 mg/1CapsuleOralPURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS24658-801
RifampinRifampin 150 mg/1CapsuleOralCoupler LLC67046-1605

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in